CVSA

Value Q1, 25Q2, 25Q3, 25 TTM Total revenue 462.29 M503.38 M487.03 M 1.91 B Gross profit 261.12 M297.75 M275.7 M 1.09 B Operating expenses 376.81 M392.27 M395.69 M 1.54 B Selling/general/admin expenses 175.73 M182.79 M184.11 M 723.49 M Research & development ——— — Operating income 85.48 M111.11 M91.34 M 364.86 M Non-Operating Income, Total 4.97 M3.41 M464 K 13.87 M Interest expense, net of interest capitalized 11.09 M10.92 M13.63 M 46.49 M Non-Operating Income, excl. Interest Expenses -8.6 M-9.21 M-13.4 M -39.56 M Unusual income/expense 2.49 M1.7 M232 K 6.93 M Pretax income 76.87 M101.9 M77.94 M 325.3 M Equity in earnings ——— — Taxes 15.81 M25.73 M19.96 M 75.63 M Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations 61.06 M76.17 M57.98 M 249.68 M Discontinued operations 770 K205 K-16.34 M -15.62 M Net income 61.83 M76.38 M41.64 M 234.06 M Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 61.83 M76.38 M41.64 M 234.06 M Basic earnings per share (Basic EPS) 1.712.141.21 6.56 Diluted earnings per share (Diluted EPS) 1.672.111.2 6.41 Average basic shares outstanding 36.11 M35.73 M34.28 M — Diluted shares outstanding 37.06 M36.23 M34.78 M — EBITDA 99.43 M125.59 M106.21 M 430.81 M EBIT 85.48 M111.11 M91.34 M 364.86 M Cost of revenue 201.17 M205.64 M211.33 M 816.59 M Other cost of goods sold ——— — Depreciation & amortization (cash flow) 13.95 M14.48 M14.87 M 65.95 M